Predictors of frequent oral analgesic use in rheumatoid arthritis
- PMID: 25225510
- PMCID: PMC4163216
- DOI: 10.12669/pjms.305.5112
Predictors of frequent oral analgesic use in rheumatoid arthritis
Abstract
Objective: The main objective of this study was to determine the predictors of frequent oral analgesic use among Rheumatoid Arthritis (RA) patients who were prescribed with the above medication on an 'as-needed' basis.
Methods: Patients with RA were recruited consecutively from the Rheumatology outpatient clinics in this cross-sectional study. The sociodemographic data, frequency of oral analgesic intake, Patient Global Assessment (PGA) scores and HAQ (Health Assessment Questionnaire) scores were determined by interviewing the subjects. Subjects were divided into 2 groups; frequent users (3 days and above in a week) and less frequent users (less than 3 days in a week).
Results: In a total of 112 subjects, 39 (34.8%) were frequent analgesic users. Both the HAQ and PGA scores were significantly higher among the frequent users (p<0.05). Using multivariate analysis, the HAQ scores (p=0.015, odds ratio 3.161 [95% confidence interval of 1.246-8.015]) and PGA scores (p=0.039 odds ratio 1.291 [95% confidence interval of 1.012-1.646]) were found to be independent predictors of frequent analgesic use.
Conclusions: Our study confirms that the frequency of analgesic intake in Rheumatoid Arthritis has a significant relationship with patient-reported functional capacity and well being.
Keywords: Analgesic; Rheumatoid arthritis.
Figures
Similar articles
-
Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index.Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S31-42. Clin Exp Rheumatol. 2005. PMID: 16273783
-
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.Clin Rheumatol. 2018 Jun;37(6):1503-1510. doi: 10.1007/s10067-018-3998-1. Epub 2018 Feb 21. Clin Rheumatol. 2018. PMID: 29468340
-
Patient- and physician-reported outcomes from two phase 3 randomized studies (RAJ3 and RAJ4) of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis.Arthritis Res Ther. 2021 Aug 24;23(1):221. doi: 10.1186/s13075-021-02590-z. Arthritis Res Ther. 2021. PMID: 34429152 Free PMC article. Clinical Trial.
-
Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.Value Health. 2015 Dec;18(8):1008-15. doi: 10.1016/j.jval.2015.09.2941. Epub 2015 Nov 17. Value Health. 2015. PMID: 26686785 Clinical Trial.
-
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).Autoimmun Rev. 2017 May;16(5):548-554. doi: 10.1016/j.autrev.2017.03.002. Epub 2017 Mar 6. Autoimmun Rev. 2017. PMID: 28279841 Review.
References
-
- Odegard S, Finset A, Kvien TK, Mowinckel P, Uhlig T. Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol. 2005;34(6):441–447. DOI: 10.1080/03009740510018633. - PubMed
-
- Smedstad LM, Moum T, Vaglum P, Kvien TK. The impact of early rheumatoid arthritis on psychological distress. A comparison between 238 patients with RA and 116 matched controls. Scand J Rheumatol. 1996;25(6):377–382. - PubMed
-
- Al MJ, Maniadakis N, Grijseels EW, Janssen M. Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands. Value Health. 2008;11(4):589–599. DOI: 10.1111/j.1524-4733.2007.00303.x. - PubMed
-
- Bloom BS. Cost of treating arthritis and NSAID-related gastrointestinal side-effects. Aliment Pharmacol Ther. 1988;2(Suppl 1):131–138. - PubMed
LinkOut - more resources
Full Text Sources